Global Psoriasis Treatment Drugs Market Research Report 2024

Report ID: 1886067 | Published Date: Sep 2024 | No. of Page: 100 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 TNF Inhibitors
        1.2.3 Interleukin Inhibitors
        1.2.4 Vitamin D Analogs
        1.2.5 Corticosteroids
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Psoriasis Treatment Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Oral
        1.3.3 Parenteral
        1.3.4 Topical
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Psoriasis Treatment Drugs Market Perspective (2017-2028)
    2.2 Psoriasis Treatment Drugs Growth Trends by Region
        2.2.1 Psoriasis Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Psoriasis Treatment Drugs Market Dynamics
        2.3.1 Psoriasis Treatment Drugs Industry Trends
        2.3.2 Psoriasis Treatment Drugs Market Drivers
        2.3.3 Psoriasis Treatment Drugs Market Challenges
        2.3.4 Psoriasis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Psoriasis Treatment Drugs Players by Revenue
        3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2017-2022)
        3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Psoriasis Treatment Drugs Revenue
    3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio
        3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2021
    3.5 Psoriasis Treatment Drugs Key Players Head office and Area Served
    3.6 Key Players Psoriasis Treatment Drugs Product Solution and Service
    3.7 Date of Enter into Psoriasis Treatment Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Treatment Drugs Breakdown Data by Type
    4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2023-2028)
5 Psoriasis Treatment Drugs Breakdown Data by Application
    5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Psoriasis Treatment Drugs Market Size (2017-2028)
    6.2 North America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    6.3 North America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Psoriasis Treatment Drugs Market Size (2017-2028)
    7.2 Europe Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Psoriasis Treatment Drugs Market Size (2017-2028)
    9.2 Latin America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Psoriasis Treatment Drugs Introduction
        11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Detail
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Psoriasis Treatment Drugs Introduction
        11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.2.5 Allergan Recent Development
    11.3 Dermira
        11.3.1 Dermira Company Detail
        11.3.2 Dermira Business Overview
        11.3.3 Dermira Psoriasis Treatment Drugs Introduction
        11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.3.5 Dermira Recent Development
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Detail
        11.4.2 Eli Lilly Business Overview
        11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction
        11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.4.5 Eli Lilly Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Detail
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Psoriasis Treatment Drugs Introduction
        11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.5.5 Novartis Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck Psoriasis Treatment Drugs Introduction
        11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Detail
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction
        11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.7.5 Johnson & Johnson Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Detail
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Psoriasis Treatment Drugs Introduction
        11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.8.5 Pfizer Recent Development
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Detail
        11.9.2 AstraZeneca Business Overview
        11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction
        11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.9.5 AstraZeneca Recent Development
    11.10 AbbVie
        11.10.1 AbbVie Company Detail
        11.10.2 AbbVie Business Overview
        11.10.3 AbbVie Psoriasis Treatment Drugs Introduction
        11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.10.5 AbbVie Recent Development
    11.11 LEO Pharma
        11.11.1 LEO Pharma Company Detail
        11.11.2 LEO Pharma Business Overview
        11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction
        11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.11.5 LEO Pharma Recent Development
    11.12 Biogen
        11.12.1 Biogen Company Detail
        11.12.2 Biogen Business Overview
        11.12.3 Biogen Psoriasis Treatment Drugs Introduction
        11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.12.5 Biogen Recent Development
    11.13 Galectin Therapeutics
        11.13.1 Galectin Therapeutics Company Detail
        11.13.2 Galectin Therapeutics Business Overview
        11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction
        11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.13.5 Galectin Therapeutics Recent Development
    11.14 Cellceutix
        11.14.1 Cellceutix Company Detail
        11.14.2 Cellceutix Business Overview
        11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction
        11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.14.5 Cellceutix Recent Development
    11.15 Bayer
        11.15.1 Bayer Company Detail
        11.15.2 Bayer Business Overview
        11.15.3 Bayer Psoriasis Treatment Drugs Introduction
        11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
        11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Psoriasis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of TNF Inhibitors
    Table 3. Key Players of Interleukin Inhibitors
    Table 4. Key Players of Vitamin D Analogs
    Table 5. Key Players of Corticosteroids
    Table 6. Key Players of Others
    Table 7. Global Psoriasis Treatment Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Psoriasis Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Psoriasis Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Psoriasis Treatment Drugs Market Share by Region (2017-2022)
    Table 11. Global Psoriasis Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Psoriasis Treatment Drugs Market Share by Region (2023-2028)
    Table 13. Psoriasis Treatment Drugs Market Trends
    Table 14. Psoriasis Treatment Drugs Market Drivers
    Table 15. Psoriasis Treatment Drugs Market Challenges
    Table 16. Psoriasis Treatment Drugs Market Restraints
    Table 17. Global Psoriasis Treatment Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Psoriasis Treatment Drugs Market Share by Players (2017-2022)
    Table 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2021)
    Table 20. Ranking of Global Top Psoriasis Treatment Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Psoriasis Treatment Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Psoriasis Treatment Drugs Product Solution and Service
    Table 24. Date of Enter into Psoriasis Treatment Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Psoriasis Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Psoriasis Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2017-2022)
    Table 32. Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2023-2028)
    Table 34. North America Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Amgen Company Detail
    Table 45. Amgen Business Overview
    Table 46. Amgen Psoriasis Treatment Drugs Product
    Table 47. Amgen Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 48. Amgen Recent Development
    Table 49. Allergan Company Detail
    Table 50. Allergan Business Overview
    Table 51. Allergan Psoriasis Treatment Drugs Product
    Table 52. Allergan Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 53. Allergan Recent Development
    Table 54. Dermira Company Detail
    Table 55. Dermira Business Overview
    Table 56. Dermira Psoriasis Treatment Drugs Product
    Table 57. Dermira Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 58. Dermira Recent Development
    Table 59. Eli Lilly Company Detail
    Table 60. Eli Lilly Business Overview
    Table 61. Eli Lilly Psoriasis Treatment Drugs Product
    Table 62. Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 63. Eli Lilly Recent Development
    Table 64. Novartis Company Detail
    Table 65. Novartis Business Overview
    Table 66. Novartis Psoriasis Treatment Drugs Product
    Table 67. Novartis Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 68. Novartis Recent Development
    Table 69. Merck Company Detail
    Table 70. Merck Business Overview
    Table 71. Merck Psoriasis Treatment Drugs Product
    Table 72. Merck Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 73. Merck Recent Development
    Table 74. Johnson & Johnson Company Detail
    Table 75. Johnson & Johnson Business Overview
    Table 76. Johnson & Johnson Psoriasis Treatment Drugs Product
    Table 77. Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 78. Johnson & Johnson Recent Development
    Table 79. Pfizer Company Detail
    Table 80. Pfizer Business Overview
    Table 81. Pfizer Psoriasis Treatment Drugs Product
    Table 82. Pfizer Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 83. Pfizer Recent Development
    Table 84. AstraZeneca Company Detail
    Table 85. AstraZeneca Business Overview
    Table 86. AstraZeneca Psoriasis Treatment Drugs Product
    Table 87. AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 88. AstraZeneca Recent Development
    Table 89. AbbVie Company Detail
    Table 90. AbbVie Business Overview
    Table 91. AbbVie Psoriasis Treatment Drugs Product
    Table 92. AbbVie Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 93. AbbVie Recent Development
    Table 94. LEO Pharma Company Detail
    Table 95. LEO Pharma Business Overview
    Table 96. LEO Pharma Psoriasis Treatment DrugsProduct
    Table 97. LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 98. LEO Pharma Recent Development
    Table 99. Biogen Company Detail
    Table 100. Biogen Business Overview
    Table 101. Biogen Psoriasis Treatment DrugsProduct
    Table 102. Biogen Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 103. Biogen Recent Development
    Table 104. Galectin Therapeutics Company Detail
    Table 105. Galectin Therapeutics Business Overview
    Table 106. Galectin Therapeutics Psoriasis Treatment DrugsProduct
    Table 107. Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 108. Galectin Therapeutics Recent Development
    Table 109. Cellceutix Company Detail
    Table 110. Cellceutix Business Overview
    Table 111. Cellceutix Psoriasis Treatment DrugsProduct
    Table 112. Cellceutix Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 113. Cellceutix Recent Development
    Table 114. Bayer Company Detail
    Table 115. Bayer Business Overview
    Table 116. Bayer Psoriasis Treatment DrugsProduct
    Table 117. Bayer Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 118. Bayer Recent Development
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Psoriasis Treatment Drugs Market Share by Type: 2021 VS 2028
    Figure 2. TNF Inhibitors Features
    Figure 3. Interleukin Inhibitors Features
    Figure 4. Vitamin D Analogs Features
    Figure 5. Corticosteroids Features
    Figure 6. Others Features
    Figure 7. Global Psoriasis Treatment Drugs Market Share by Application in 2021 & 2028
    Figure 8. Oral Case Studies
    Figure 9. Parenteral Case Studies
    Figure 10. Topical Case Studies
    Figure 11. Psoriasis Treatment Drugs Report Years Considered
    Figure 12. Global Psoriasis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Psoriasis Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Psoriasis Treatment Drugs Market Share by Region: 2021 VS 2028
    Figure 15. Global Psoriasis Treatment Drugs Market Share by Players in 2021
    Figure 16. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Psoriasis Treatment Drugs Revenue in 2021
    Figure 18. North America Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Psoriasis Treatment Drugs Market Share by Country (2017-2028)
    Figure 20. United States Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Psoriasis Treatment Drugs Market Share by Country (2017-2028)
    Figure 24. Germany Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Psoriasis Treatment Drugs Market Share by Region (2017-2028)
    Figure 32. China Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Psoriasis Treatment Drugs Market Share by Country (2017-2028)
    Figure 40. Mexico Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Psoriasis Treatment Drugs Market Share by Country (2017-2028)
    Figure 44. Turkey Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Amgen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 47. Allergan Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 48. Dermira Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 49. Eli Lilly Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 50. Novartis Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 51. Merck Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 52. Johnson & Johnson Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 53. Pfizer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 54. AstraZeneca Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 55. AbbVie Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 56. LEO Pharma Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 57. Biogen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 58. Galectin Therapeutics Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 59. Cellceutix Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 60. Bayer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Frequently Asked Questions
Psoriasis Treatment Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Psoriasis Treatment Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Psoriasis Treatment Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bio-based Phenol

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

JFET RF Transistors

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More